Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Cue Biopharma, Inc. (CUE) had Receiveable Turnover of 3.23 for the most recently reported fiscal year, ending 2023-12-31.
| Income Statement Financials | |
$5.49M |
|
$-50.73M |
|
-- |
|
$5.49M |
|
$57.64M |
|
$-52.15M |
|
$1.42M |
|
$-50.73M |
|
$-50.73M |
|
$-50.73M |
|
$-50.73M |
|
$-50.73M |
|
$-50.73M |
|
$-52.15M |
|
$-51.79M |
|
45.75M |
|
45.75M |
|
$-1.11 |
|
$-1.11 |
|
| Balance Sheet Financials | |
$51.45M |
|
$0.80M |
|
$10.08M |
|
$61.53M |
|
$17.08M |
|
$4.20M |
|
$7.36M |
|
$24.45M |
|
$37.09M |
|
$37.09M |
|
$37.09M |
|
47.22M |
|
| Cash Flow Statement Financials | |
$-39.96M |
|
$25.00M |
|
$11.86M |
|
$51.76M |
|
$48.66M |
|
$-3.10M |
|
$8.18M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.01 |
|
-- |
|
-- |
|
0.10 |
|
0.22 |
|
100.00% |
|
-949.89% |
|
-949.89% |
|
-943.35% |
|
-924.10% |
|
-924.10% |
|
$-39.96M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
|
Receiveable Turnover |
3.23 |
112.89 |
|
-136.80% |
|
-136.80% |
|
-82.45% |
|
-122.88% |
|
$0.79 |
|
$-0.87 |
|
$-0.87 |
|